we feel strongly about having the regular order so that members on both sides can offer their ideas and their amendments.
These kinds of ethical issues just keep coming up.
We commend the Finance Committee Chairman Orrin Hatch and Ranking Member Ron Wyden for recently introducing legislation, S. 1827.
the President has for months and months poured gasoline on the fires of uncertainty in the private insurance marketplace.
The more this committee and the Senate can do to make biotechnology drugs more reflective of the competitive principles embodied in Hatch-Wa...
I am very concerned about the possibility that some may be using the concept of flexibility to roll back consumer protection.
I would hope that the era of just moving forward on something partisan in a rush has stopped...
The record, the actual factual record, does not show that.
But it just seems to me that sunlight would be an antiseptic here that would really make a difference.
Price increases happen because the providers of these pharmaceutical products have the power to do so because taxpayers foot the bill.
There are only two ways to hold people accountable for costs at the end of the day: you can have a consumer-driven system or a government-dr...